Global IVD Market 2024
16 Apr 2025
16 Apr 2025
In-vitro diagnostics (IVD) are at the heart of modern healthcare. From detecting diseases to monitoring wellness, these tools are indispensable. In 2024, the global IVD market tells a compelling storyβnot just of major players, but of emerging markets with immense potential.
The largest IVD markets in 2024 are:
United States β $33.78B
China β $9.31B
Japan β $5.35B
South Korea β $4.25B
Germany β $4.25B
These countries dominate in terms of spending, infrastructure, and maturity of diagnostics adoption.
Several countries outside the top 5 are showing rapid growth and high potential:
Kenya: $54M IVD market, expanding with digital health adoption
Vietnam: $338M, growing fast due to public health investments
Nigeria: $119M, driven by infectious disease diagnostics
These emerging markets are beginning to modernize their diagnostics ecosystems and represent significant future opportunity.
Itβs not just about the total market size. Spend per capita shows where demand might still be underdeveloped and ready to grow:
United States: ~$99 per person
China: ~$6.50 per person
India: ~$1.30 per person
Indonesia: ~$1.60 per person
Marketers can use this lens to identify regions suited for digital-first or affordable diagnostics solutions.
This country-level breakdown can support:
Product localization strategies based on country maturity
Investor and VC pitch decks to highlight untapped markets
Regional distribution and channel partner planning
Government and public health grant writing or donor targeting
United States β $33.78B
China β $9.31B
Japan β $5.35B
South Korea β $4.25B
Germany β $4.25B
India β $1.90B
Brazil β $2.00B
France β $2.90B
Italy β $3.00B
United Kingdom β $1.97B
Mexico β $1.55B
Canada β $1.96B
Spain β $1.99B
Argentina β $1.28B
Russia β $1.40B
Iran β $1.02B
Turkey β $1.04B
Saudi Arabia β $1.18B
South Africa β $528M
Thailand β $503M
These countries offer large populations but relatively low current IVD spend β ideal for entry-level or digital-first diagnostics:
India β 1.4B population, $1.9B market (~$1.3/person)
Indonesia β 277M, $435M (~$1.6/person)
Pakistan β 240M, $88M (~$0.37/person)
Nigeria β 223M, $119M (~$0.53/person)
Bangladesh β 173M, $57M (~$0.33/person)
Ethiopia β 127M, $44M (~$0.35/person)
Philippines β 117M, $316M (~$2.7/person)
Vietnam β 99M, $249M (~$2.5/person)
π Americas
United States β $33.78B
Brazil β $2.00B
Mexico β $1.55B
Argentina β $1.28B
Canada β $1.96B
Colombia β $578M
Chile β $511M
π Africa
Nigeria β $119M
South Africa β $528M
Kenya β $54M
Egypt β $227M
Ethiopia β $44M
Ghana β $23M
π Asia-Pacific
China β $9.31B
India β $1.90B
Japan β $5.35B
South Korea β $4.25B
Vietnam β $249M
Indonesia β $435M
Philippines β $316M
Thailand β $503M
π Europe
Germany β $4.25B
France β $2.90B
Italy β $3.00B
Spain β $1.99B
United Kingdom β $1.97B
Russia β $1.40B
Poland β $803M
The IVD market is a patchwork of opportunity. Leaders should be watching both the giants and the fast-followers. With a smart, data-driven strategy, even small or low-spend markets can deliver big returns. Whether you're building market entry plans, pitching to investors, or deploying diagnostics at scale β understanding country-level dynamics is key to success in 2024 and beyond.